Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FBP1 | P09467 | 2/20 | 0.76 |
| ▸ | BCL9 | O00512 | 4/20 | 0.62 |
| ▸ | CTNNB1 | P35222 | 4/20 | 0.62 |
| ▸ | ABCB1 | P08183 | 7/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | SLCO2B1 | O94956 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | HPGD | P15428 | 2/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.59 |
| ▸ | DAPK1 | P53355 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | CDK1 | P06493 | 2/20 | 0.59 |
| ▸ | CCNB1 | P14635 | 2/20 | 0.59 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.59 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.59 |
| ▸ | FTO | Q9C0B1 | 2/20 | 0.59 |
| ▸ | CA12 | O43570 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13857095 | 0.87 | MEN1 (0.77) | FBP1BCL9CTNNB1ABCB1ALDH1A1 | |
| SCHEMBL29575800 | 0.87 | MEN1 (0.77) | FBP1BCL9CTNNB1ABCB1ALDH1A1 | |
| Herbacetin SCHEMBL872691 | 0.87 | FBP1 (1.00) | FBP1BCL9CTNNB1ABCB1ALDH1A1 | |
| Herbacetin SCHEMBL31442430 | 0.87 | FBP1 (1.00) | FBP1BCL9CTNNB1ABCB1ALDH1A1 | |
| SCHEMBL12640012 | 0.85 | MAPT (0.61) | FBP1BCL9CTNNB1ABCB1ALDH1A1 | |
| SCHEMBL1608916 | 0.82 | FBP1 (0.71) | FBP1BCL9CTNNB1ABCB1ALDH1A1 | |
| SCHEMBL30095422 | 0.82 | FBP1 (0.71) | FBP1BCL9CTNNB1ABCB1ALDH1A1 | |
| SCHEMBL16682485 | 0.81 | FBP1 (0.78) | FBP1BCL9CTNNB1ABCB1ALDH1A1 | |
| SCHEMBL26204956 | 0.81 | FBP1 (0.78) | FBP1BCL9CTNNB1ABCB1ALDH1A1 | |
| SCHEMBL31026217 | 0.80 | MEN1 (0.68) | FBP1BCL9CTNNB1ABCB1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220281903-A1 | FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES | MÜHLBAUER TECHNOLOGY GMBH (DE) | 2022-09-08 | — | — | US | claimed |
| EP-4017585-A1 | FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES | Mühlbauer Technology GmbH (DE) | 2022-06-29 | — | — | EP | claimed |
| WO-2021032844-A1 | FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES | MÜHLBAUER TECHNOLOGY GMBH (DE) | 2021-02-25 | — | — | WO | claimed |
| US-20040057908-A1 | Oral compositions and use thereof | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2004-03-25 | — | — | US | claimed |
| EP-1399119-A2 | ORAL COMPOSITIONS AND USE THEREOF | University of Rochester (US) | 2004-03-24 | — | — | EP | claimed |
| WO-2002047615-A2 | ORAL COMPOSITIONS AND USE THEREOF | UNIVERSITY OF ROCHESTER (US) | 2002-06-20 | — | — | WO | claimed |
| US-12590111-B2 | Flavonoid derivative for treating dental caries | MÜHLBAUER TECHNOLOGY GMBH (DE) | 2026-03-31 | — | — | US | disclosed |
| US-20240156877-A1 | COMPOSITIONS AND USES THEREFOR | MELCARE MEDICAL PTY LTD (AU) | 2024-05-16 | — | — | US | disclosed |
| EP-4368178-A1 | COMPOSITIONS OF HONEY AND GLUCONIC ACID AND USES THEREFOR | Melcare Medical Pty Ltd (AU) | 2024-05-15 | — | — | EP | disclosed |
| CN-118001410-A | Composition and use thereof | 麦尔凯亚医学股份有限公司 | 2024-05-10 | — | — | CN | disclosed |
| US-20220281903-A1 | FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES | MÜHLBAUER TECHNOLOGY GMBH (DE) | 2022-09-08 | — | — | US | disclosed |
| EP-4017585-A1 | FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES | Mühlbauer Technology GmbH (DE) | 2022-06-29 | — | — | EP | disclosed |
| US-11154578-B2 | Compositions and methods of use | MELGARE MEDICAL PTY LTD (AU) | 2021-10-26 | — | — | US | disclosed |
| WO-2021032844-A1 | FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES | MÜHLBAUER TECHNOLOGY GMBH (DE) | 2021-02-25 | — | — | WO | disclosed |
| US-20170209500-A1 | COMPOSITIONS AND METHODS OF USE | MELCARE MEDICAL PTY LTD (AU) | 2017-07-27 | — | — | US | disclosed |
| WO-2016011498-A1 | COMPOSITIONS AND METHODS OF USE | MELCARE MEDICAL PTY LTD (AU) | 2016-01-28 | — | — | WO | disclosed |
| US-20040057908-A1 | Oral compositions and use thereof | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2004-03-25 | — | — | US | disclosed |
| EP-1399119-A2 | ORAL COMPOSITIONS AND USE THEREOF | University of Rochester (US) | 2004-03-24 | — | — | EP | disclosed |
| WO-2002047615-A2 | ORAL COMPOSITIONS AND USE THEREOF | UNIVERSITY OF ROCHESTER (US) | 2002-06-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220281903-A1 | FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES | ITGA8, ITGAL, ITGB2 | FBP1 1395/4885BCL9 1811/4885CTNNB1 1961/4885 |
| US-12590111-B2 | Flavonoid derivative for treating dental caries | ITGA8, ICAM1, ITGA2 | FBP1 443/4885BCL9 1472/4885CTNNB1 4442/4885 |
| US-20040057908-A1 | Oral compositions and use thereof | UGGT1, DPM1, B4GALT1 | FBP1 359/4885BCL9 3354/4885CTNNB1 4188/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.